The members of the American Association for Cancer Research (AACR) have elected five members to serve on the AACR board of directors for the 2015–2018 term and four members to serve on the nominating committee for the 2015–2017 term. They will begin their terms at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18–22.
Board of Directors
The following five members were elected to the board of directors:
George D. Demetri, MD, Professor of Medicine at Harvard Medical School, Director of the Ludwig Center at Harvard, Director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Senior Vice President for Experimental Therapeutics and Staff Physician at Dana-Farber Cancer Institute, Coassociate Director of Clinical Science at Dana-Farber/Harvard Cancer Center, Associate Physician at Brigham and Women’s Hospital, Affiliate Physician at Massachusetts General Hospital, and a Visiting Clinical Attending Physician at the National Cancer Institute.
Dr. Demetri is currently a member of the AACR Chemistry in Cancer Research Working Group.
Patricia M. LoRusso, DO, Professor of Medicine in the Division of Oncology at Yale University, and Associate Director of Innovative Medicine at Yale Cancer Center.
Dr. LoRusso is currently Chair-Elect Designate of the AACR Women in Cancer Research Council, Cochair of the Annual Meeting Clinical Trials Committee, and an editorial board member of Molecular Cancer Therapeutics.
Richard M. Marais, MD, Director and Senior Group Leader of the Molecular Oncology Group at the Cancer Research UK Manchester Institute, Center Colead at the Cancer Research UK Lung Cancer Centre of Excellence, Scientific Codirector at the Belfast-Manchester Movember Centre of Excellence, and Professor of Molecular Oncology at the University of Manchester.
Dr. Marais is currently Cochair of the AACR Annual Meeting Education Committee and the Program Committee, a scientific editor of Cancer Discovery, a member of the Cancer Immunology Working Group, and Cochair of the Stand Up To Cancer-Cancer Research UK Translational Research Fellowship Joint Scientific Advisory Committee.
Elaine R. Mardis, PhD, Robert E. and Louise F. Dunn Distinguished Professor of Medicine, Codirector of the Genome Institute, Professor in the Departments of Genetics and Molecular Microbiology, and Assistant Professor in the Department of Molecular Microbiology at the Washington University in St. Louis School of Medicine.
Dr. Mardis is currently Senior Editor of Molecular Cancer Research and a member of the Special Conferences Committee and the Clinical and Translational Cancer Research Steering Committee.
Edith A. Perez, MD, Deputy Director at Large at the Mayo Clinic Cancer Center, Serene M. and Frances C. Durling Professor of Medicine, Director of the Breast Cancer Translational Genomics Program, and Chair of the Breast Cancer Specialty Council at the Mayo Clinic College of Medicine.
Dr. Perez is currently Chair-Elect of the AACR Minorities in Cancer Research Council and a member of the Science Policy and Government Affairs Committee and the Finance and Audit Committee.
Nominating Committee
The following four members were elected to the nominating committee:
Kornelia Polyak, MD, PhD, Professor of Medicine at Harvard Medical School, Professor of Medical Oncology at Dana-Farber Cancer Institute, and Principal Faculty at the Harvard Stem Cell Institute.
Dr. Polyak is currently a member of the AACR Outstanding Investigator Award for Breast Cancer Research Committee and the Pediatric Cancer Working Group.
Charles L. Sawyers, MD, Chairperson of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, a Howard Hughes Medical Institute Investigator, and Professor in the Cell and Developmental Biology Program at the Weill Cornell Graduate School of Medical Sciences of Cornell University. He is also a fellow of the AACR Academy.
Dr. Sawyers served as AACR president from 2013 to 2014. He is currently a scientific editor of Cancer Discovery and Coleader of the Stand Up To Cancer-Prostate Cancer Foundation Prostate Cancer Dream Team, “Precision Therapy of Advanced Prostate Cancer.”
William R. Sellers, MD, Vice President and Global Head of Oncology at Novartis Institutes of BioMedical Research, Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, Associate Member of the Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, and Associate Physician at Brigham and Women’s Hospital.
Dr. Sellers served as Chair of the AACR special conference, “Translation of the Cancer Genome,” in 2009 and 2015, as well as Keynote Speaker in 2011, and as Chair of the Research Grant Review Committee.
Inder M. Verma, PhD, Professor in the Laboratory of Genetics at The Salk Institute and Adjunct Professor in the Department of Biology at the University of California, San Diego. He is also a fellow of the AACR Academy.
Dr. Verma served as a program committee member of the AACR international conference, “New Horizons in Cancer Research: Biology to Prevention and Therapy,” in India, and on the International Affairs Committee. ■
